Pfizer Slovakia’s Country Manager and Lead Internal Medicine / Pfizer Innovative Health Branislav Budke discusses the success of Pfizer in Slovakia, the challenges of the healthcare system, and political changes that can potentially contribute towards the easier market access of innovative treatments, due to his dual role as Head of the AIFP, the country’s Association of Innovative Pharmaceutical Industry.
As president of the Association of Innovative Pharmaceutical Industry in Slovakia (AIFP), could you please talk us through your main ambitions and the main challenges the association is facing at the moment?
As an industry, we are on our way to establishing partner relationships with the new government which actually seems to be more open to discussion than the previous one
